The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Tredje AP fonden

Tredje AP fonden decreased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,877 shares of the medical device company’s stock after selling 487 shares during the quarter. Tredje AP fonden’s holdings in Cooper Companies were worth $2,696,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. Treasurer of the State of North Carolina boosted its stake in Cooper Companies by 0.9% during the fourth quarter. Treasurer of the State of North Carolina now owns 22,861 shares of the medical device company’s stock worth $8,652,000 after buying an additional 212 shares during the last quarter. Hsbc Holdings PLC boosted its position in shares of Cooper Companies by 55.3% during the 4th quarter. Hsbc Holdings PLC now owns 87,718 shares of the medical device company’s stock valued at $33,188,000 after acquiring an additional 31,234 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Cooper Companies in the first quarter valued at about $2,211,000. Whittier Trust Co. increased its position in Cooper Companies by 298.9% during the first quarter. Whittier Trust Co. now owns 11,940 shares of the medical device company’s stock worth $1,211,000 after purchasing an additional 8,947 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. boosted its holdings in Cooper Companies by 43.1% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company’s stock valued at $3,076,000 after purchasing an additional 10,616 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total value of $172,956.03. Following the sale, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other Cooper Companies news, CFO Brian G. Andrews sold 24,788 shares of the business’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the transaction, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the sale, the chief accounting officer now owns 4,818 shares in the company, valued at $520,488.54. The disclosure for this sale can be found here. Insiders have sold a total of 141,381 shares of company stock worth $14,927,361 in the last quarter. 2.00% of the stock is owned by company insiders.

Cooper Companies Trading Up 0.5 %

NASDAQ COO opened at $111.10 on Friday. The Cooper Companies, Inc. has a one year low of $75.93 and a one year high of $112.38. The firm has a 50 day simple moving average of $97.09 and a 200-day simple moving average of $95.37. The firm has a market cap of $22.12 billion, a price-to-earnings ratio of 65.35, a PEG ratio of 2.60 and a beta of 0.98. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.84 earnings per share. Equities research analysts anticipate that The Cooper Companies, Inc. will post 3.66 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Robert W. Baird upped their price target on Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research note on Thursday, August 29th. Morgan Stanley raised their price objective on Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Tuesday, September 10th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Finally, Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and lifted their price target for the company from $107.00 to $115.00 in a research report on Tuesday, July 16th. Four investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $115.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.